Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Debt to Equity (2019 - 2025)

Burning Rock Biotech has reported Debt to Equity over the past 4 years, most recently at $0.0 for Q4 2025.

  • For Q4 2025, Debt to Equity changed N/A year-over-year to $0.0; the TTM value through Dec 2025 reached $0.0, changed N/A, while the annual FY2025 figure was $0.0, N/A changed from the prior year.
  • Debt to Equity for Q4 2025 was $0.0 at Burning Rock Biotech, up from $0.0 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.01 in Q1 2021 and troughed at $0.0 in Q4 2021.